TRP_1170x120_12-19-19

Qualitest

Endo wraps up Par Pharma acquisition

Endo wraps up Par Pharma acquisition

DUBLIN, Ireland — Endo International plc has completed its $8.05 billion acquisition of Par Pharmaceutical Holdings Inc. from leading global private investment firm TPG. Endo said Monday that with the closing of the deal, announced in May, its U.S. Generics segment that includes Par Pharmaceutical and Qualitest will be named Par Pharmaceutical, an Endo International